Phosphonium polymers for gene delivery by Loczenski Rose, Vanessa et al.
  
  
Phosphonium polymers for gene delivery 
Vanessa Loczenski Rose,a,b Francesca Mastrotto,a Giuseppe Mantovania   
As published in Polymer Chemistry (RSC) as accepted manuscript - Polymer Chemistry, 
2016, DOI: 10.1039/C6PY01855F 
 
Phosphonium salt-containing polymers have very recently started to emerge as attractive 
materials for the engineering non-viral gene delivery systems. Compared to more frequently 
utilised ammonium-based polymers, some of these materials can enhance binding of nucleic 
acid at lower polymer concentration, and mediate good transfections efficiency, with low 
cytotoxicity. However, for years one of the main hurdles for their widespread application has 
been the lack of general routes for their synthesis. To date a range of polymerisation techniques 
have been explored, with the majority of them focussing on radical polymerisation, especially 
controlled radical polymerisation (CRP) techniques – ATRP, NMP and RAFT polymerisation 
- both by polymerisation of phosphonium monomers or by post-polymerisation modification 
of polymer intermediates. This review article aims at discussing key differences and 
similarities between phosphonium-and other analogous cations, how these affect binding to 
polynucleotides, and will provide an overview of the phosphonium polymer systems that have 
been utilised for gene delivery.  
 
1. Introduction 
The recent years have witnessed a growing interest in the development of polymer-based non-viral 
systems for the delivery of polynucleotides such as siRNA and pDNA, both in vitro and in vivo.1-5 To 
this aim, synthetic polymers are particularly attractive, due to increasingly efficient chemical routes for 
their synthesis, and the possibility to further modify the delivery systems through post polymerisation 
strategies.6 Within this context, controlled radical polymerisation (CRP, also known as reversible-
deactivation radical polymerisation, RDRP) techniques have been extensively investigated, as they 
enable control over the polymer composition, architecture as well as molecular weight and dispersity.7, 
8 CRP techniques relevant for the synthesis of gene delivery vehicles9 are copper-mediated living radical 
polymerisation,10 especially atom transfer radical polymerisation (ATRP),11, 12 reversible addition 
fragmentation chain transfer (RAFT)13, 14 polymerisation, and nitroxide-mediated polymerisation 
(NMP).15  
One of the most common strategies to deliver oligo/polynucleotides in vitro and in vivo is to assemble 
them into polyplexes, where they are bound to suitable polymer carriers through non-covalent 
interactions between multiple copies of negatively charged nucleotide phosphate groups and 
polycationic polymers16 (Figure 1). When the polymer cationic units are nitrogen-based (ammonium), 
  
  
the relative proportion of positively charged groups within the polymer and phosphate anions in 
oligo/polynucleotides is referred to as the N+/P- ratio. This parameter is critical in the formulation of 
polyplexes, as it can affect their overall size, transfection efficiency (non-viral vectors have typically 
subviral performances17), and most importantly cell cytotoxicity.12  
 
  
Figure 1. Assembly of non-covalent polymer-polynucleotide polyplexes. 
 
Conversely, the potential of phosphonium-containing polymers for nucleic acid delivery has not yet 
been fully recognised, most likely due to the few synthetic routes for their synthesis in satisfactory yield 
and purity, and the cost, toxicity and pyrophoric nature of some of the organic phosphine precursors 
necessary for their preparation.18, 19 To date only a relatively small number of studies successfully 
implemented phosphonium-based polymers for gene delivery.20 This review will provide a 
comprehensive overview of the state of the art of the field. 
 
2. Phosphonium versus ammonium cations: similarities, differences and potential advantages 
for gene delivery 
Phosphonium-containing polymers have been investigated as potential alternatives to their 
corresponding ammonium analogues. Being generally less prone to undergo Hofmann elimination and 
Menschutkin degradation, macromolecules containing phosphonium cations have often a superior 
thermal stability.20 Enhanced stability of phosphonium monomers can potentially provide additional 
advantages – e.g. their use under more challenging experimental conditions, thus allowing to expand 
polymerisation techniques for the synthesis of phosphonium-based macromolecules.  In gene delivery, 
studies reported improved abilities of phosphonium polymers due to bind nucleic acids, enhance 
transfection efficiency, and decrease cell cytotoxicity.21, 22 Moreover, these materials were found to bind 
polynucleotides at lower P+/P- ratios (in analogy to N+/P- ratio for ammonium-containing polymers, 
P+/P- ratio is the molar ratio between the positively charged phosphonium groups (P+) in the polymer, 
and the negatively charged phosphate group (P-) of the polynucleotide) than their corresponding 
ammonium analogues.21-23 Although specific mechanistic studies have not been carried out as yet, these 
results could be explained, at least in part, with the intrinsic differences between nitrogen- and 
phosphorous-based cations (Figure 2). 
  
  
 
Figure 2. Factors influencing the interaction between positively charged ammonium and 
phosphonium centres, and nucleic acids: Nitrogen vs. Phosphorus cations. 
 
P vs. N: chemico-physical considerations. Both nitrogen and phosphorus elements belong to Group 
15 of the periodic table, and possess 5 valence electrons. Being below nitrogen within the same group, 
phosphorus (atomic number 15, electronegativity 2.19) has larger atomic radius and is less 
electronegative than both nitrogen (atomic number 7, electronegativity 3.04) and carbon 
(electronegativity 2.55) (Figure 2). Ammonium salts are therefore intrinsically smaller than their 
phosphonium analogues (C-N: ~1.53 Å; C-P: ~1.81 Å), which also allow them to be closer to their 
anionic counterions.24 Importantly, different partial charges and charge distributions have been 
suggested, where for phosphonium ions the positive charge is centered at the P atom, whereas in the 
ammonium group is comparatively more distributed through the adjacent carbons, resulting in a weaker 
cationic charge in the ammonium groups.21, 25 Consequently, in quaternary ammonium moieties the 
adjacent hydrogen atoms (α- and β- methylene hydrogens) are also more positively charged, which 
results in stronger hydrogen bonding, further shortening contact distances with their anionic 
counterions.24  
Ab initio calculations performed by Colby and co-workers with tetrabutylphosphonium/ammonium 
salts further supported the differences in charge distributions of ammonium/phosphonium cations and 
their adjacent groups. Being less electronegative than the adjacent carbons, the phosphorus atom of n-
Bu4P+ carries a positive charge (+1.1e) leaving the outer atoms to share (-0.1e).25 This partially negative 
shell surrounding the cationic P atom in turn provides a partial shielding which weakens the coulombic 
interaction with anionic counterions. Conversely, being more electronegative that the bound carbon 
atoms, in n-Bu4N+ nitrogen carries a negative charge (-0.5e) leaving the outer atoms to share (+1.5 e), 
which results in higher attraction towards anions. Coutinho and co-workers came to similar conclusion 
when analysing charge distribution of tetra-alkyl-phosphonium and –ammonium ionic liquids, again 
suggesting that the P atom possessed higher positive charge, whilst the N centre delocalised more the 
positive charge towards adjacent alkyl groups.26  
  
  
Within a gene delivery context, evidence suggesting phosphonium’s lowered attraction towards 
anions would provide enhanced DNA release, thus partially explaining the increased transfection, 
although Frechet and co-workers have also suggested that the more localised charge on the phosphorus 
atom, might potentially favour nucleic acid binding with phosphonium-based polymers.21  
 
P vs. N: toxicity profiles in vitro and in vivo. A potential benefit of some phosphonium-containing 
materials is a lower cytotoxicity compared to their ammonium analogues. This was first described in a 
study by Stekar et al. which focussed at identifying analogues of anti-neoplastic synthetic phospholipids 
edelfosine and miltefosine, with better tolerability and higher cytostatic activity. Novel analogues were 
synthesised by replacing the nitrogen atom (N) of 2-O-methyl-1-O-octadecyl-rac-glyceryl-3-
phosphocholine and octadecyl phosphosphocholine with either arsenic (As) or phosphorus (P) (Figure 
3), and the resulting phosphonium and arsonium phospholipids were found to have comparatively lower 
acute toxicity in a mouse model, when compared to their parent choline phospholipids.27 However, the 
new analogues retained a similar antineoplastic activity of their parent phospholipids, as assessed in 
vitro in various cell lines (lymphocytic leukemia cells (L1210), KB cells (a subline of HeLa cells) and 
DS cells (B lymphocyte)) and in vivo using rat bearing 7,12-dimethylbenz(a)anthracene induced 
carcinomas. Although the exact mechanism(s) behind the observed differences was not investigated at 
this stage, the reduced acute toxicity resulting in weaker parasympathomimetic activity could be 
potentially related to the greater covalent radii of phosphonium and arsonium ions, which resulted in 
larger complexes.27  
 
 
Figure 3. Antineoplastic active phospholipids octadecyl phosphosphocholine (left) and 2-O-methyl-1-
O-octadecyl-rac-glyceryl-3-phosphocholine (right) analogues with different Group 15 quaternary 
centres (N, P, and As) investigated by Stekar et al.27 
A study by Clément and co-coworkers on cationic phosphonolipids demonstrated that changing the 
nature of the cationic polar head from ammonium to phosphonium or arsonium, resulted in more 
efficient DNA transfection of β-galactosidase in airway epithelial cells (CFT1 cells) and HeLa cells. 
Furthermore, reduced cytotoxicity was observed in myelogenous leukemia cells (K562) transfected 
with a phosphonolipids containing a phosphorus or arsenic-based quaternary groups compared to the 
corresponding ammonium lipids.28 In a subsequent work the same authors investigated a large library 
of cationic phosphonolipids with variable structural parameters, including the nature of cationic 
quaternary moieties - ammonium, phosphonium or arsonium, as part of gene delivery vectors, both in 
vitro and in vivo.29  Using a luciferase assay, it was found that the replacement of ammonium groups 
  
  
with analogue phosphonium or arsenium moieties improved cell transfection and reduced cytotoxicity 
in a range of cell lines (HeLa, CFT1, K562).  
In terms of phosphonium-containing polymers, a seminal work by Frechet and co-workers showed 
that structurally analogous polyacrylates  bearing triethyl-phosphonium repeating units had lower 
cytotoxicity compared to the corresponding triethyl-ammonium analogues.21 Cell viability was assessed 
using a metabolic WST-1 proliferation assay employing a range of polymer concentrations (50-500 µg 
mL-1), and was measured 48 hours after polymer exposure.  Furthermore, better cell viability was 
observed for the triethyl-phosphonium based polymer after transfection with siRNA polyplexes in 
comparison to its ammonium analogues. In a subsequent work using similar polymers in 3T3 mouse 
cell line, we found no significant difference in cytotoxicity between phosponium and ammonium-
containing polymers.30  
Using tributyl- and triethyl-ammonium and phosphonium polystyrenes, no differences in cytotoxicity 
profiles were found for both polymers and corresponding polynucleotide polyplexes in HeLa cells, as 
estimated by a MTT cell viability assay.22  
Overall, current evidence suggests that phosphonium polymers generally possess a cytotoxicity 
profile equivalent or more favourable than their ammonium-based analogues, which could open the 
way for a more widespread application of these materials in gene delivery. 
 
3. Phosphonium-based polymers for gene delivery. 
Phosphonium salts and their corresponding polymers have been investigated in a range of 
applications which span from ion exchange membranes18, 31 and selectively permeable membranes,32 
treatment of drinking water,33 to cationic biocides,34-37 cell-penetrating agents,38 and ionomers.39, 40 
Various polymerisation and post-polymerisation approaches have been utilised to generate 
phosphonium-containing polymers, however only relatively recently phosphonium polymers have been 
exploited as biological active polymers with antimicrobial properties34-37, 41-44 and for the delivery of 
nucleic acid21, 23, 30. Examples of phosphonium-based polymers investigated for gene delivery are shown 
in Figure 4. 
 
  
  
 
Figure 4. Examples of of phosphonium-containing polymers investigated for delivery of DNA and 
siRNA. A) (4-vinylbenzyl)tributylphosphonium chloride22; B) (4-vinylbenzyl)tributylphosphonium 
chloride-containing block polymers23; C) triethylphosphonium poly(meth)acrylates21, 30; D) 
triphenylphosphonium bromide-substitited PEI45; E) N-phosphonium-containing chitosan41. 
Controlled radical polymersation (CRP): synthesis of phosphonium-based polymers and their 
use for gene delivery. This section will first illustrate several approaches to synthesise phosphonium-
containing polymers by CRP, then will discuss examples where these polymers were utilised for gene 
delivery.  
The first examples of synthesis of phosphonium polymers by CRP were reported by Wang and 
Lowe.46, 47 RAFT polymerisation of 4-vinylbenzyl (trimethylphosphonium) chloride and 4-vinylbenzyl 
(triphenylphosphonium) chloride styrenic monomers was carried out under aqueous conditions at 80°C 
employing 2-(2-carboxy-ethylsulfanylthiocarbonylsulfanyl) propionic acid trithiocarbonate RAFT 
CTA. Polymerisations followed linear first-order kinetics and were well-controlled, with 
homopolymers featuring Đ ≤ 1.07. The resulting macro-CTAs were further chain extended with 4-
vinylbenzoic acid to give diblock copolymers polyampholytes - polyzwitterions that contain, or 
potentially contain, both cationic and anionic residues located on different repeat units – which were 
found to self-assemble in supramolecular structures at pH 2.0, below the pKa of its benzoic acid 
repeating units (Figure 5).  
  
  
 
Figure 5. poly(4-vinylbenzyl (trimethylphosphonium) chloride)-b-(4-vinylbenzoic acid) 
polyampholytes synthesised by Wang and Lowe by aqueous RAFT polymerisation.46  
RAFT polymerisation was also employed in a subsequent work by Stokes, Beyer and co-workers to 
synthesise a library of well-defined poly((trimethyl(4-vinylbenzyl)phosphonium chloride)-r-styrene) 
random copolymers with a range (15 - 98 mol %) of cationic repeating units.48  Copolymers were 
designed to be potentially incorporated within anion exchange membranes, and their thermal properties 
were evaluated by differential scanning calorimetry and thermogravimetric analysis. Aiming at 
analogous applications, Balsara’s group synthesised a range of poly[styrene-b-((2-
acryloxy)ethyltributyl-phosphonium bromide)] diblock copolymers by RAFT polymerisation.49 A pSty 
macro CTA was first prepared, followed by chain extension with bromoethyl acrylate, and the resulting 
reactive copolymer treated with tributhylphosphine to afford the desired phosphonium-containing 
diblock copolymers (Figure 6). 
 
Figure 6. Poly[styrene-b-((2-acryloxy)ethyltributyl-phosphonium bromide) prepared by  RAFT 
polymerisation by Balsara and co-workers.  
 
 
Nitroxide-mediated polymerisation (NMP) was successfully utilised by Long and coworkers to 
synthesise a family of phosphonium-containing ABA triblock copolymers, where the number of ionic 
repeating units as well as the length of the hydrophobic alkyl substituents on the phosphonium cation 
were systematically varied.50  Polymerisation from a (DEPN-terminated poly(n-butyl acrylate) di-
functional nitroxide initiator of (tributyl-4-vinylbenzyl phosphonium chloride or trioctyl-4-vinylbenzyl 
phosphonium chloride monomers at 125°C in DMF afforded the desired ABA block copolymers 
  
  
(Figure 7). These materials were assessed for their potential to be incorporated in alkaline fuel cell 
membranes and for melt processing, by analysing their thermal and thermo-mechanical properties as 
well as self-assembly properties, by employing differential scanning calorimetry, glass transition 
measurements, dynamic mechanical analysis and TEM.   
 
 
Figure 7. Synthesis of phosphonium containing triblock polymers by NMP. Adapted from Ye et al.31 
 
The first example of phosphonium polymers prepared by ATRP was reported by Borguet and 
Tsarevsky, who employed initiators for continuous activator regeneration atom transfer radical 
polymerisation (ICAR ATRP) to synthesise well-defined poly(4-vinylbenzyltriphenylphosphonium) 
materials (Figure 8).51 Interestingly, initial attempts to polymerise vinylbenzyltriphenylphosphonium 
chloride via ICAR ATRP conditions were unsuccessful, likely due to displacement of the tris(2-
pyridylmethyl)amine (TPMA) ligand from Cu(I) and Cu(II) ATRP catalytic species by monomer 
chloride counter ions. Pleasingly, the replacement of chloride- with less coordinating tetrafluoroborate 
counterions in the phosphonium monomers resulted in successful polymerisation, using ethyl-2-
bromoisobutyrate as the initiator, TPMA as the ligand, and AIBN as the radical initiator, at 70°C in 
DMF (Figure 8). To confirm the end-group fidelity of the process, chain extension was carried out again 
by ICAR ATRP, using either styrene to give block-copolymers, or 4VBTPPBF4 to afford a higher 
molecular weight homopolymer. The final polymers had Mn 15.0-28.4 kDa and Đ = 1.31-1.51. 
  
  
 
Figure 8. Synthesis of phosphonium-containing polystyrenes by ICAR ATRP. 4-
vinylbenzyltriphenylphosphonium chloride monomer was first converted into its corresponding 
tetrafluoborate salt to allow polymerisation under ICAR ATRP conditions. Adapted from Borguet and 
Tsarevsky.51 
 
Long and co-workers synthesised phosphonium-containing AB-diblock polymers for DNA delivery 
by RAFT polymerisation.23 The polymers consisted of a substituted polystyrene cationic phosphonium 
block for DNA complexation, and a second block synthesised from oligo-(ethylene glycol)9 methyl 
ether methacrylate or 2-methacryloyoxyethyl phosphorylcholine for improved colloidal stability of the 
resulting delivery system. The degree of polymerisation of the cationic DNA-binding block was 
systematically varied, to give a library of AB copolymers with Mn: 33.8-54.4 kDa, with low dispersities 
(Đ ≤ 1.09). Efficient DNA binding was observed at low (+/-) ratios –P+/P- - in a gel shift assay. Low 
transfection efficiencies were observed in monkey kidney fibroblast (COS-7) and HeLa (cervical cancer 
cell line) cells. However, using a Luciferase assay good transfection efficiencies, comparable to 
commercially available transfection agent jet-PEI (a linear poly(ethylene imine)), were demonstrated 
in hepatoma-derived cells (HepaRG) with good cell viabilities (≥80%) at low polymer-DNA ratio (+/-
) ratio (2), whilst EGFP-C1 plasmid was used for confocal microscopy experiments.  
  
  
 
Figure 9. Phosphonium-based diblock polymers for application in gene delivery, synthesised via RAFT 
polymerisation by Long and co-workers.23 
 
Following a key study by Frechet and co-workers21 (vide infra), we recently synthetised a library of 
quaternary ammonium and phosphonium polymethacrylates for short interfering RNA delivery.30 The 
nature of the charged heteroatom (N vs P) as well as the length of the spacer separating the cationic 
units from the polymer backbone (oxyethylene vs. trioxyethylene) were systematically varied to identify 
structure-function relationships for these materials (Figure 10). Results showed that both longer and 
more flexible trioxyethylene spacers, and phosphonium cations resulted in RNA polyplexes that were 
more stable in the presence of heparin competitive polyanions. Interestingly, whilst all RNA polyplexes 
were efficiently internalized by GFP-expressing 3T3 cells, no appreciable siRNA-mediated GFP 
knockdown was observed, possibly due to inefficient polyplex endosomal escape. However, Survivin 
gene knockdown was achieved in HeLa cells by replacing siRNA with multimerized liRNA, showing 
that the macromolecular structure of RNA can be key for RNA interference. 
 
 
Figure 10. Quaternary ammonium and phosphonium polymethacrylates for RNA delivery 
synthesised via RAFT polymerisation by Mantovani and co-workers.30  
 
 
Phosphonium polymers for gene delivery prepared with other techniques. Closely related to CRP, 
‘conventional’ free radical polymerisation has also been utilised to synthesise polycationic polymers 
for gene delivery. Long and co-workers polymerised styrenic ammonium and phosphonium monomers 
to generate a small library of poly(triethyl-(4-vinylbenzyl)ammonium chloride) (PTEA), poly(tributyl-
  
  
(4-vinylbenzyl)ammonium chloride) (PTBA), poly(triethyl-(4-vinylbenzyl)phosphonium chloride) 
(PTEP) and poly- (tributyl-(4-vinylbenzyl)phosphonium chloride) (PTBP)22. A key aim of this study 
was to study structure activity relationships for these materials, by varying the length of the polymer N- 
and P-alkyl substituents. DNA binding assays with a gWiz-Luc plasmid showed more efficient DNA 
binding for phosphonium polymers over their ammonium analogues. Furthermore, 
tributylphosphonium-based polymers (PTBP) showed significant higher transfection activity of 
luciferase DNA (p>0.05) over the corresponding triethylphosphonium- and tributylammonium 
(PTBA)-polymers and commercially available Superfect in serum free conditions, again underlying the 
importance of the macromolecular features of the polycationic complexing polymer in transfection 
efficiency.  
Following the application of polyphosphonium polymers for pDNA delivery, Frechet and co-workers 
demonstrated for the first time the application of phosphonium-containing polymers for siRNA delivery 
(Figure 11)21 A library of polyphosphonium  polymers was generated in two steps from commercially 
available polyacrylic acid (PAA) which was first esterified with 2-[2-(2-chloroethoxy)ethoxy]ethanol 
and the resulting intermediate was then reacted with different organic phosphines - triethylphosphine, 
tri(tert-butylphosphine), tris(3-hydroxy propyl) phosphine, triphenylphospine - and triethylamine. The 
triphenylphosphine-derived polymer was insoluble in water, whilst the tri(tert-butylphosphine) 
derivative was found to be extremely cytotoxic even at low polymer concentrations. Both polymers 
were therefore not utilised to generate siRNA delivery vehicles. However, the triethylphosphonium 
acrylate based polymer gave transfection efficiencies of 65%, while maintaining extremely good cell 
viability (100%) in HeLa-Luc (luciferase expressing) cells. In comparison its polymeric ammonium 
analogue gave only 25% transfection efficiency and 85% cell viability. This study suggested that these 
phosphonium-containing polymers were less cytotoxic and gave higher transfection efficiency than 
their corresponding ammonium polycations.   
 
  
  
 
Figure 11. Phosphonium- and ammonium-based polyacrylates synthetised by Frechet and co-workers 
for siRNA delivery. Adapted from Ornelas-Megiatto et al.21  
 
The preparation of novel ammonium-phosphonium (N-P) hybrid polymers containing secondary and 
tertiary amines along with phosphonium moieties in a single polymeric chain has been described by 
Kumar and co-workers (Figure 12).45 A set of N-butyl(triphenylphosphonium bromide) (BTP)-grafted-
linear polyethylenimine (lPEI) polymers (BTP-g-lP), was prepared by reaction of (4-
bromobutyl)triphenyl-phosphonium bromide with lPEI to introduce butyl(triphenylphosphonium 
bromide) pendant groups  onto the lPEI polymeric backbone. Different lPEI:BTP molar ratios were 
used, resulting in a library of grafted polymers with different BTP content (10, 20, 30, 40 and 50%). 
Polyplexes of polymers and DNA had hydrodynamic diameters in the 249–307 nm range and a positive 
surface charge (+31-34 mV), as measured by DLS and zeta potential respectively. The GFP 
fluorescence and hence ability to transfect DNA was measured spectrofluorometrically in cell lysates 
after 36 hours of incubation with polyplexes.  The polymer containing 30% BTP (BTP-g-lP3/pDNA) 
showed the best results with ~3.6 and 7.1-fold higher transfection efficiency in lung cancer (A549) and 
breast cancer (MCF-7) cells, respectively, compared to native lPEI. The same complex displayed ~1.8–
8.4 fold higher transfection compared to commercially available Lipofectamine, Superfect and 
GenePORTER 2 in both cell lines investigated. In addition, the potential of BTP-g-IP3 for siRNA 
delivery was evaluated in a GFP expressing MCF-7 cell line, and improved gene knockdown was shown 
over commercial available Lipofectamine. All formulations tested did not show significant cytotoxicity 
at the concentrations employed for the transfection experiments.  
 
  
  
 
Figure 12. Synthesis of BTP-g-lPEI polymers with 10-50% substitution of grafted BTP on lPEI, 
adapted from Kumar and co-workers.45 
 
N-phosphonium-containing chitosans (NPCSs) with variable degrees of substitution (12.1 and 21.5 
mol%) have been synthesised by Guo’s group as DNA-complexing macromolecules (Figure ).52 
Chitosan was reacted with (5-carboxypentyl) triphenylphosphonium bromide followed by purification 
by precipitation and dialysis. The size of NPCS/DNA complexes was found to be in the 110-160 nm 
range as measured by DLS. A MTT cell viability assay using human embryonic kidney (HEK 293) and 
HeLa cells revealed a comparable concentration-dependent decrease of cell viability for NPCSs and 
branched-PEI (25 kDa, utilised in this study as a reference transfecting polymer), using polymer 
concentrations ranging from 2 to 200 µg mL-1. In both cell lines, NPCSs were found to be more 
cytotoxic than chitosan, but marginally less toxic than branched PEI. Transfection with EGFP-N1 
plasmid showed increased DNA uptake using the NPCS/DNA complexes (N/P 16:1) over chitosan 
alone. The transfection efficiency with NPCS with a degree of substitution of 21.5% was comparable 
to the efficiency of branched PEI (bPEI) on HeLa cells at pH 6.5. 
 
 
Figure 13. N-phosphonium chitosans (NPCSs) with variable degrees of substitution, investigated by 
Guo and co-workers as potential gene delivery vehicles.52  
4. Conclusions 
The application of phosphonium-containing polymers for biological purposes, such as nucleic acid 
delivery is still in its infancy, but has started to receive increasing interest. As discussed in this review, 
due to the peculiar properties of quaternised phosphonium centres, when appropriately designed 
phosphonium-based polymer systems can possess improved polymer properties over their 
corresponding ammonium-based materials, such as binding affinity to polynucleotides, transfection 
  
  
efficiency and lower cytotoxicity. At present, more studies are required to further confirm those findings 
and understand the physico-chemical differences of ammonium- and phosphonium based gene delivery 
systems in vitro and in vivo.  
Overall, the application of phosphonium-based polymers for nucleic acid delivery are still restricted, 
due to limited synthetic routes currently available. With few exceptions, the polymer systems discussed 
within this review were mostly prepared by conventional or controlled radical polymerisation (CRP) 
techniques, with the latter being particularly attractive due to the potential to produce polymeric 
materials with great control over their macromolecular features. This in turn may result in the 
development of classes of novel materials which could complement and expand the range of 
polynucleotide delivery systems currently available. 
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